
    
      The overall goal of this protocol is to evaluate the biodistribution of [18F]MNI-1054 as a
      LSD1 targeted radiopharmaceutical. The specific objectives are:

        -  To determine the radiation dosimetry of [18F]MNI-1054

        -  To assess the safety and tolerability of a single dose of [18F]MNI-1054
    
  